Epidemiology of Covid-19 Positive Patients Admitted In a Dedicated Covid Hospital

Vikas  Yadav; Sunil  Kumar; Renu  Yadav

doi:10.5455/njcm.20210403103753

Authors

Vikas Yadav Department of Community Medicine, Medical Branch Sukna
Sunil Kumar Department of Microbiology, Command Hospital Kolkata, Kolkata
Renu Yadav Department of Pharmacology, Armed Forces Medical College, Pune

DOI:

https://doi.org/10.5455/njcm.20210403103753

Keywords:

Covid-19, herd immunity, vaccination, mortality, RTPCR

Abstract

Introduction: The pandemic of Covid-19 was declared on 11 march 2020 by WHO.

Methods: The study was carried out in a dedicated Covid 19 hospital on 1493 patients. All patients who tested positive for Covid-19 by RTPCR were included in the study and the outcome was analysed.

Result: Most of the patients were symptomatic (64.97%). The asymptomatic patients recovered faster than symptomatic and the difference was statistically significant. The most common symptoms were fever (38.3%), tiredness (20.6%) and cough (17.8%). Only 0.8% patients died due to the novel corona virus.

Conclusion: The mortality due to the virus in India is not alarming and we need to consider starting focusing back on other diseases as well. The mean age of the deceased was 58.42 which highlights that elderly at a greater risk to succumb to disease and hence should be preferred for as priority one for vaccination against the disease. The numbers of Covid-19 cases have reduced considerably over last few months in the country, but this does not mean that the pandemic has gone away. We need to be cautious, use this opportunity to vaccinate the maximum population to prevent second wave of the disease.

References

India G of M of H and FW. Clinical Management Protocol: COVID-19, MHFW, GoI. 2020; Available from: https://www .mohfw.gov.in/pdf/ClinicalManagementProtocolforCOVID19.pdf. Accessed Feb 1st,, 2021.

WHO Director-General’s opening remarks at the media brief-ing on COVID-19 - 8 June 2020. Available from: https:// www.who.int/director-general/speeches/detail/who-direc tor-general-s-opening-remarks-at-the-media-briefing-on-covid-19---8-june-2020.html. Accessed Feb 3rd, 2021.

Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157-160.

Zhang AL, Wang Y, Molina MJ. Erratum: Identifying airborne transmission as the dominant route for the spread of COVID-19. Proceedings of the National Academy of Sciences of the United States of America. 2020;117:14857-14863

Coronavirus disease (COVID-19): How is it transmitted? Available from: https://www.who.int/emergencies/diseases/novel -coronavirus-2019/question-and-answers-hub/q-a-detail/cor onavirus-disease-covid-19-how-is-it-transmitted.html. Accessed Feb 4th, 2021

Commentary E. COVID - 19 : Epidemiology and Public Health Aspects. 2020;111–6.

Zhou L, Med M, Tong Y, Ph D, Ren R, Med M, et al. Early Trans-mission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. 2020;1–9.

Centers US, Control D. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases : Estimation and Application Objective : To estimate the length of the incubation period of COVID- Design : Setting : News reports and press releases f. 2020;2–3.

Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. American Medical Association; 2020;323 p. 1406–7.

Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19.International Journal of Antimicrobial Agents 2020;55.

Terms U, Province H. Coronavirus disease 2019 (COVID-19): Epidemiology , virology, and prevention. 2020;2019:1–31.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Articles Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 2020;6736(20):1–10.

Chowdhury SD, Oommen AM. Epidemiology of COVID-19. Journal of digestive endoscopy. 2020;11(1):3–7.

Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19. Available from: https://www.who.int/ emer-gencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/herd-immunity-lockdowns-and-covid-19.html. Accessed Feb 5th 2021

Advice for the public [Internet]. Available from: https://www. who.int/emergencies/diseases/novel-coronavirus-2019/adv ice-for-public.html. Accessed Feb 5th

India, Day 1: World’s Largest Coronavirus Lockdown Begins – The New York Times [Internet]. Available from: https://www. nytimes.com/2020/03/25/world/asia/india-lockdown-coro navirus.html?auth=link-dismiss-google1tap. Accessed on feb 05th, 2021.

Ministry of health and family welfare, directorate general of health services, EMR division. Guidelines to be followed on detection of suspect/confirmed COVID-19 case in a non-COVID Health Facility. New-delhi, India: MoHFW.2020 p 1-3.

Ministry of health and family welfare. Guidelines on Clinical management of severe acute respiratory illness (SARI) in suspect/confirmed novel coronavirus (nCoV) cases. New-delhi, India: MoHFW.2020 p 1-11

Agarwal N, Biswas B, Lohani P. Epidemiological determinants of COVID-19 infection and mortality: A study among patients presenting with severe acute respiratory illness during the pandemic in Bihar, India. Niger Postgrad Med J. 2020; 27(4): 293–301.

Bhandari S, Shaktawat AS, Sharma R, Dube A, Kakkar S, Banerjee S, et al. A preliminary clinico-epidemiological por-trayal of COVID-19 pandemic at a premier medical institution of North India. Ann Thorac Med. 2020;15(3):146–50.

Sakurai A, Sasaki T, Kato S, Hayashi M, Tsuzuki S, Ishihara T, et al. Natural History of Asymptomatic SARS-CoV-2 Infection. N Engl J Med. 2020;383(9):885–6.

Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 in-fections. Nat Med. 2020;26(8):1200–4.

India Coronavirus: 10,847,790 Cases and 155,195 Deaths - Worldometer [Internet]. Available from: https://www.worldo me-ters.info/coronavirus/country/india/html. Accessed Feb 9th, 2021.

India: WHO Coronavirus Disease (COVID-19) Dashboard | WHO Coronavirus Disease (COVID-19) Dashboard. Available from: https://covid19.who.int/region/searo/country/in.html. Ac-cessed Feb 9th, 2021.

Episode #18 - COVID-19 - Immunity after recovery from COVID-19. Available from: https://www.who.int/ emergen-cies/diseases/novel-coronavirus-2019/media-resources/ science-in-5/episode-18-covid-19-immunity-after-recovery-from-covid-19.htm. Accessed Feb 9th, 2021.

• COVID-19 mortality rate by country | Statista. Available from: https://www.statista.com/statistics/1105914/ coro-navirus-death-rates-worldwide/html. Accessed Feb 9th, 2021.

WHO coronavirus (Covid-19) Dashboard. Available from: https://covid19.who.int/table.html. Accessed Feb 9th, 2021.

India’s COVID-19 Mortality Too Low to Divert All Our Atten-tion Away from Other Diseases - The Wire Science. Available from: https://science.thewire.in/health/indias-covid-19-mortality-is-too-low-to-warrant-closure-of-other-health-services/. Accessed Feb 9th, 2021.

Coronavirus | WHO | Regional Office for Africa [Internet]. Available from: https://www.afro.who.int/publications/ co-rona virus.html. Accessed Feb 9th, 2021.

MacKenzie JS, Smith DW. COVID-19: A novel zoonotic disease caused by a coronavirus from China: What we know and what we don’t. Microbiol Aust. 2020;41(1):45–50.

WHO EMRO | Questions and answers | COVID-19 | Health topics. Available from: http://www.emro.who.int/health-topics/corona-virus/questions-and-answers.html. Accessed Feb 9th, 2021.